Quince Therapeutics Investor Relations Material
Latest events
Investor Update
Quince Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Quince Therapeutics Inc
Access all reports
Quince Therapeutics Inc is a U.S.-based biopharmaceutical company focused on the development and commercialization of targeted therapeutics for debilitating and rare diseases. The company’s pipeline includes treatments designed to improve drug delivery and tissue targeting for enhanced efficacy and safety. Quince Therapeutics leverages proprietary platforms and collaborates with partners to advance its clinical and preclinical programs. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Quince Therapeutics Inc
The ThinkEquity Conference 2024
Quince Therapeutics Inc
Investor Presentation
Quince Therapeutics Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
QNCX
Country
🇺🇸 United States